日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial

恩扎卢胺、达罗卢胺和安慰剂对健康志愿者认知相关脑区血流量的影响比较：一项随机交叉试验

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-023-00959-5
Williams, Steven C R; Mazibuko, Ndaba; O'Daly, Owen; Zurth, Christian; Patrick, Fiona; Kappeler, Christian; Kuss, Iris; Cole, Patricia E
神经科学
发表日期：2023
文献求助 收藏

Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment

雄激素受体抑制剂达罗鲁胺在健康受试者和肝肾功能不全患者中的临床药代动力学

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-021-01078-y
Zurth, Christian; Nykänen, Pirjo; Wilkinson, Gary; Taavitsainen, Päivi; Vuorela, Annamari; Huang, Funan; Reschke, Susanne; Koskinen, Mikko
信号转导
免疫/内分泌
发表日期：2022
文献求助 收藏

Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

达罗鲁胺在非转移性去势抵抗性前列腺癌患者中具有临床意义的药物相互作用和群体药代动力学评价：III期ARAMIS试验的预设分析和事后分析结果

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-019-00674-0
Shore, Neal; Zurth, Christian; Fricke, Robert; Gieschen, Hille; Graudenz, Kristina; Koskinen, Mikko; Ploeger, Bart; Moss, Jonathan; Prien, Olaf; Borghesi, Gustavo; Petrenciuc, Oana; Tammela, Teuvo L; Kuss, Iris; Verholen, Frank; Smith, Matthew R; Fizazi, Karim
肿瘤
前列腺癌
肿瘤免疫
MIS
发表日期：2019
文献求助 收藏

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

达罗鲁胺（ODM-201）是一种新一代雄激素受体拮抗剂，在日本转移性去势抵抗性前列腺癌患者中进行的I期研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-017-3417-3
Matsubara, Nobuaki; Mukai, Hirofumi; Hosono, Ako; Onomura, Mai; Sasaki, Masaoki; Yajima, Yoko; Hashizume, Kensei; Yasuda, Masanobu; Uemura, Miho; Zurth, Christian
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏

Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

更正：达罗鲁胺（ODM-201，一种新一代雄激素受体拮抗剂）治疗日本转移性去势抵抗性前列腺癌患者的I期研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-017-3433-3
Matsubara, Nobuaki; Mukai, Hirofumi; Hosono, Ako; Onomura, Mai; Sasaki, Masaoki; Yajima, Yoko; Hashizume, Kensei; Yasuda, Masanobu; Uemura, Miho; Zurth, Christian
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏

Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases

单剂量氯化镭-223 (BAY 88-8223) 在日本去势抵抗性前列腺癌骨转移患者中的药代动力学

期刊:Annals of Nuclear Medicine
影响因子:2.5
doi:10.1007/s12149-016-1093-8
Yoshida, Keisuke; Kaneta, Tomohiro; Takano, Shoko; Sugiura, Madoka; Kawano, Tsuyoshi; Hino, Ayako; Yamamoto, Tou; Shizukuishi, Kazuya; Kaneko, Masato; Zurth, Christian; Inoue, Tomio
肿瘤
前列腺癌
肿瘤免疫
发表日期：2016
文献求助 收藏

Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive

使用两种透皮避孕系统和一种标准复方口服避孕药对炔雌醇剂量和生物利用度进行药代动力学概述

期刊:International Journal of Clinical Pharmacology and Therapeutics
影响因子:0.7
doi:10.5414/CP202064
Hofmann, Birte; Reinecke, Isabel; Schuett, Barbara; Merz, Martin; Zurth, Christian
发表日期：2014
文献求助 收藏

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

多位点序列分型：一种用于鉴定致病微生物群体内克隆的便携式方法

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.95.6.3140
Maiden, M C; Bygraves, J A; Feil, E; Morelli, G; Russell, J E; Urwin, R; Zhang, Q; Zhou, J; Zurth, K; Caugant, D A; Feavers, I M; Achtman, M; Spratt, B G
微生物学
发表日期：1998
文献求助 收藏